
China SXT Pharmaceuticals SXTC
$ 1.35
2.27%
Annual report 2025
added 03-21-2026
China SXT Pharmaceuticals Cash Conversion Cycle 2011-2026 | SXTC
Annual Cash Conversion Cycle China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -108 | -177 | -155 | -143 | 163 | 155 | 57.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 163 | -177 | -29.7 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Ocular Therapeutix
OCUL
|
174 | $ 7.85 | -2.73 % | $ 1.47 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 19.59 | 0.31 % | $ 916 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
-54.4 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Pfizer
PFE
|
189 | $ 27.4 | -0.63 % | $ 156 B | ||
|
Precigen
PGEN
|
91.2 | $ 3.83 | -1.79 % | $ 1.2 B | ||
|
Avid Bioservices
CDMO
|
85.5 | - | - | $ 789 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
PTC Therapeutics
PTCT
|
35.9 | $ 66.68 | -0.48 % | $ 5.3 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
32.4 | $ 0.8 | 1.48 % | $ 428 M | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
230 | $ 13.61 | -1.16 % | $ 2.26 B | ||
|
Regeneron Pharmaceuticals
REGN
|
152 | $ 750.41 | -0.84 % | $ 78.5 B | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-193 | $ 1.08 | -0.92 % | $ 22.2 M | ||
|
REGENXBIO
RGNX
|
53.1 | $ 7.98 | -3.39 % | $ 412 M | ||
|
Rigel Pharmaceuticals
RIGL
|
123 | $ 26.1 | -1.02 % | $ 469 M | ||
|
Relay Therapeutics
RLAY
|
53.3 | $ 9.68 | -4.35 % | $ 1.38 B |